SCHEMBL5043466

SCHEMBL5043466

CO[C@H](C(=O)NCc1ccc(C#N)cc1)c1c(F)ccc(Nc2ccccc2)c1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.45
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
HIF1A Q16665 1/20 0.40
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
CNR2 P34972 2/20 0.37
MT-CO2 P00403 1/20 0.36
EPHX2 P34913 1/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
AKR1B1 P15121 1/20 0.35
PPARA Q07869 1/20 0.35
KDR P35968 1/20 0.35
POLB P06746 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043462 1.00 PKM (0.45) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5140223 0.86 PKM (0.42) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5140221 0.86 PKM (0.42) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5037281 0.86 PKM (0.42) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5047731 0.84 PKM (0.43) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5041491 0.84 PKM (0.42) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5041495 0.84 PKM (0.42) PKMSLC1A3SLC1A2HIF1ASCN5A
SCHEMBL5041187 0.84 F7 (0.47) PKM
SCHEMBL5041191 0.84 F7 (0.47) PKM
SCHEMBL5041552 0.83 PKM (0.48) PKMSLC1A3SLC1A2HIF1ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 PKM 4225/4885SLC1A3 2652/4885SLC1A2 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.